Cover Image

Physiologically‐based pharmacokinetic model‐based translation of OATP1B‐mediated drug-drug interactions from coproporphyrin I to probe drugs

Abstract The accurate prediction of OATP1B‐mediated drug-drug interactions (DDIs) is challenging for drug development. Here, we report a physiologically‐based pharmacokinetic (PBPK) model analysis for clinical DDI data generated in heathy subjects who received oral doses of cyclosporin A (CysA; 20 a...

Full description

Saved in:

Bibliographic Details
Main Authors:	Tatsuki Mochizuki (Author), Yasunori Aoki (Author), Takashi Yoshikado (Author), Kenta Yoshida (Author), Yurong Lai (Author), Hideki Hirabayashi (Author), Yoshiyuki Yamaura (Author), Kevin Rockich (Author), Kunal Taskar (Author), Tadayuki Takashima (Author), Xiaoyan Chu (Author), Maciej J. Zamek‐Gliszczynski (Author), Jialin Mao (Author), Kazuya Maeda (Author), Kenichi Furihata (Author), Yuichi Sugiyama (Author), Hiroyuki Kusuhara (Author)
Format:	Book
Published:	Wiley, 2022-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cluster Gauss‐Newton method analyses of PBPK model parameter combinations of coproporphyrin‐I based on OATP1B‐mediated rifampicin interaction studies
by: Takashi Yoshikado, et al.
Published: (2022)

The influence of OATP2B1 and atorvastatin on coproporphyrin isomers in rats
by: Jonny Kinzi, et al.
Published: (2023)

Relationship of hemoglobin level and plasma coproporphyrin‐I concentrations as an endogenous probe for phenotyping OATP1B
by: Yosuke Suzuki, et al.
Published: (2021)

Robust physiologically based pharmacokinetic model of rifampicin for predicting drug-drug interactions via P‐glycoprotein induction and inhibition in the intestine, liver, and kidney
by: Ryuta Asaumi, et al.
Published: (2022)

Role of OATP1B1 and OATP1B3 in Drug-Drug Interactions Mediated by Tyrosine Kinase Inhibitors
by: Dominique A. Garrison, et al.
Published: (2020)

Substantially Increased Plasma Coproporphyrin‐I Concentrations Associated With OATP1B1*15 Allele in Japanese General Population
by: Yosuke Suzuki, et al.
Published: (2021)

Physiologically‐based pharmacokinetic modeling of prominent oral contraceptive agents and applications in drug-drug interactions
by: Gareth J. Lewis, et al.
Published: (2024)

Differential Preincubation Effects of Nicardipine on OATP1B1- and OATP1B3-Mediated Transport in the Presence and Absence of Protein: Implications in Assessing OATP1B1- and OATP1B3-Mediated Drug-Drug Interactions
by: Ruhul Kayesh, et al.
Published: (2023)

Coproporphyrin I Can Serve as an Endogenous Biomarker for OATP1B1 Inhibition: Assessment Using a Glecaprevir/Pibrentasvir Clinical Study
by: Hari V. Kalluri, et al.
Published: (2021)

A Metabolomics Approach for Predicting OATP1B-Type Transporter-Mediated Drug-Drug Interaction Liabilities
by: Yang Li, et al.
Published: (2022)

Distinguishing Molecular Properties of OAT, OATP, and MRP Drug Substrates by Machine Learning
by: Anisha K. Nigam, et al.
Published: (2024)

Interactions of Potential Anti-COVID-19 Compounds with Multispecific ABC and OATP Drug Transporters
by: Ágnes Telbisz, et al.
Published: (2021)

The involvement of human organic anion transporting polypeptides (OATPs) in drug-herb/food interactions
by: Youmna Ali, et al.
Published: (2020)

Elucidating nonlinear pharmacokinetics of telmisartan: Integration of target‐mediated drug disposition and OATP1B3‐mediated hepatic uptake in a physiologically based model
by: Toshiaki Tsuchitani, et al.
Published: (2024)

Interaction of Antifungal Drugs with CYP3A- and OATP1B-Mediated Venetoclax Elimination
by: Eric D. Eisenmann, et al.
Published: (2022)

Hepatic OATP1B zonal distribution: Implications for rifampicin‐mediated drug-drug interactions explored within a PBPK framework
by: Mattie Hartauer, et al.
Published: (2024)

Clinical assessment of gepotidacin (GSK2140944) as a victim and perpetrator of drug-drug interactions via CYP3A metabolism and transporters
by: Aline Barth, et al.
Published: (2023)

Evaluation of the drug-drug interaction potential of the novel hepatitis B and D virus entry inhibitor bulevirtide at OATP1B in healthy volunteers
by: Vanessa Zhu, et al.
Published: (2023)

Mechanistic in vitro studies indicate that the clinical drug-drug interactions between protease inhibitors and rosuvastatin are driven by inhibition of intestinal BCRP and hepatic OATP1B1 with minimal contribution from OATP1B3, NTCP and OAT3
by: Robert Elsby, et al.
Published: (2023)

Physiologically‐based pharmacokinetic modeling for investigating the effect of simeprevir on concomitant drugs and an endogenous biomarker of OATP1B
by: Shinji Nakayama, et al.
Published: (2023)

Various effects of repeated rifampin dosing on coproporphyrin levels in humans
by: Jonny Kinzi, et al.
Published: (2023)

Drug Transporters ABCB1 (P-gp) and OATP, but not Drug-Metabolizing Enzyme CYP3A4, Affect the Pharmacokinetics of the Psychoactive Alkaloid Ibogaine and its Metabolites
by: Margarida L. F. Martins, et al.
Published: (2022)

Molecular Properties of Drugs Handled by Kidney OATs and Liver OATPs Revealed by Chemoinformatics and Machine Learning: Implications for Kidney and Liver Disease
by: Anisha K. Nigam, et al.
Published: (2021)

Quantitative prediction of pharmacokinetic properties of drugs in humans: Recent advance in in vitro models to predict the impact of efflux transporters in the small intestine and blood-brain barrier
by: Yoshiki Hashimoto, et al.
Published: (2022)

Physiologically based pharmacokinetic modeling for development and applications of a virtual celiac disease population using felodipine as a model drug
by: Farzaneh Salem, et al.
Published: (2023)

Recent advances in the translation of drug metabolism and pharmacokinetics science for drug discovery and development
by: Yurong Lai, et al.
Published: (2022)

Increased coproporphyrin serum levels in healthy volunteers treated with the cholesterol uptake inhibitor ezetimibe
by: Jonny Kinzi, et al.
Published: (2024)

Transcriptional Regulation of Liver-Type OATP1B3 (Lt-OATP1B3) and Cancer-Type OATP1B3 (Ct-OATP1B3) Studied in Hepatocyte-Derived and Colon Cancer-Derived Cell Lines
by: Bastian Haberkorn, et al.
Published: (2023)

Variability in In Vitro OATP1B1/1B3 Inhibition Data: Impact of Incubation Conditions on Variability and Subsequent Drug Interaction Predictions
by: Savannah J. McFeely, et al.
Published: (2020)

Role of OATP4C1 in Renal Handling of Remdesivir and its Nucleoside Analog GS-441524: The First Approved Drug for Patients with COVID-19
by: Toshihiro Sato, et al.
Published: (2021)

Ginsenoside Rb1 and Rd Remarkably Inhibited the Hepatic Uptake of Ophiopogonin D in Shenmai Injection Mediated by OATPs/oatps
by: Xiaopei Liu, et al.
Published: (2018)

Application of a PBPK model to elucidate the changes of systemic and liver exposures for rosuvastatin, carotegrast, and bromfenac followed by OATP inhibition in monkeys
by: Yaofeng Cheng, et al.
Published: (2021)

Assessing <i>Trans</i>-Inhibition of OATP1B1 and OATP1B3 by Calcineurin and/or PPIase Inhibitors and Global Identification of OATP1B1/3-Associated Proteins
by: John T. Powell, et al.
Published: (2023)

Editorial: Clinical trials in drug metabolism and transport: 2022
by: Yurong Lai, et al.
Published: (2023)

Prediction of the Pharmacokinetics of Pravastatin as an OATP Substrate Using Plateable Human Hepatocytes With Human Plasma Data and PBPK Modeling
by: Jialin Mao, et al.
Published: (2018)

Emulsomes: new lipidic carriers for drug delivery with special mention to brain drug transport
by: Shivam Singh, et al.
Published: (2023)

Montelukast Disposition: No Indication of Transporter-Mediated Uptake in OATP2B1 and OATP1B1 Expressing HEK293 Cells
by: Marie Brännström, et al.
Published: (2015)

Model‐based meta‐analysis of ethnic differences and their variabilities in clearance of oral drugs classified by clearance mechanism
by: Hiromi Sato, et al.
Published: (2023)

Physiologically‐Based Pharmacokinetic Model‐Informed Drug Development for Fenebrutinib: Understanding Complex Drug‐Drug Interactions
by: Yuan Chen, et al.
Published: (2020)

Identifying Drug-Induced Liver Injury Associated With Inflammation-Drug and Drug-Drug Interactions in Pharmacologic Treatments for COVID-19 by Bioinformatics and System Biology Analyses: The Role of Pregnane X Receptor
by: Jingjing Huang, et al.
Published: (2022)